Experimental Hematology
Volume 35, Issue 2 , Pages 305-313 , February 2007

A Novel Anti-Inflammatory Function of Human Galectin-1: Inhibition of Hematopoietic Progenitor Cell Mobilization

  • Judit Kiss

      Affiliations

    • Stem Cell Biology, National Medical Center, Budapest, Hungary
    • ,
  • Aliz Kunstár

      Affiliations

    • Stem Cell Biology, National Medical Center, Budapest, Hungary
    • ,
  • Roberta Fajka-Boja

      Affiliations

    • Lymphocyte Signal Transduction Laboratory, Institute of Genetics, Biological Research Center of Hungarian Academy of Sciences, Szeged, Hungary
    • ,
  • Valėria Dudics

      Affiliations

    • Stem Cell Biology, National Medical Center, Budapest, Hungary
    • Polyclinic of Hospitaller Brothers of St. John of God, Budapest, Hungary
    • ,
  • József Tóvári

      Affiliations

    • Department of Tumor Progression, National Institute of Oncology, Budapest, Hungary
    • ,
  • Ádám Légrádi

      Affiliations

    • Lymphocyte Signal Transduction Laboratory, Institute of Genetics, Biological Research Center of Hungarian Academy of Sciences, Szeged, Hungary
    • ,
  • Ėva Monostori

      Affiliations

    • Lymphocyte Signal Transduction Laboratory, Institute of Genetics, Biological Research Center of Hungarian Academy of Sciences, Szeged, Hungary
    • ,
  • Ferenc Uher

      Affiliations

    • Stem Cell Biology, National Medical Center, Budapest, Hungary
    • Corresponding Author InformationOffprint requests to: Ferenc Uher, Ph.D., National Medical Center, Stem Cell Biology, Diószegi ut 64., Budapest, Hungary, H-1113

Received 7 June 2006 ,Revised 22 September 2006 ,Accepted 25 September 2006.

References 

  1. Kilpatrick DC. Animal lectins: a historical introduction and overview. Biochim Biophys Acta. 2002;1572:187–197
  2. Rabinovich GA. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 1999;6:711–721
  3. Ilarregui JM, Bianco GA, Toscano MA, Rabinovich GA. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis. 2005;64(Suppl 4):iv96–iv103
  4. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature. 1995;378:736–739
  5. Fajka-Boja R, Szemes M, Ion G, Legradi A, Caron M, Monostori E. Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell lines. Immunol Lett. 2002;82:149–154
  6. Ion G, Fajka-Boja R, Kovacs F, et al. Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1. Cell Signal. 2006;18:1887–1896
  7. Matarrese P, Tinari A, Mormone E, et al. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem. 2005;280:6969–6985
  8. Ion G, Fajka-Boja R, Toth GK, Caron M, Monostori E. Role of p56lck and ZAP70-mediated tyrosine phosphorylation in galectin-1-induced cell death. Cell Death Differ. 2005;12:1145–1147
  9. Poirier F, Robertson EJ. Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development. 1993;119:1229–1236
  10. Offner H, Celnik B, Bringman TS, Casentini-Borocz D, Nedwin GE, Vandenbark AA. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol. 1990;28:177–184
  11. Rabinovich GA, Daly G, Dreja H, et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med. 1999;190:385–398
  12. Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A–induced hepatitis in mice. Hepatology. 2000;31:399–406
  13. Santucci L, Fiorucci S, Rubinstein N, et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology. 2003;124:1381–1394
  14. Baum LG, Blackall DP, Arias-Magallano S, et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol. 2003;109:295–307
  15. La M, Cao TV, Cerchiaro G, et al. A novel biological activity for galectin-1: inhibition of leukocyte–endothelial cell interactions in experimental inflammation. Am J Pathol. 2003;163:1505–1515
  16. Panepucci RA, Siufi JL, Silva WA, et al. Comparison of gene expression of umbilical cord vein and bone marrow–derived mesenchymal stem cells. Stem Cells. 2004;22:1263–1278
  17. Kadri T, Lataillade JJ, Doucet C, et al. Proteomic study of Galectin-1 expression in human mesenchymal stem cells. Stem Cells Dev. 2005;14:204–212
  18. Vas V, Fajka-Boja R, Ion G, Dudics V, Monostori E, Uher F. Biphasic effect of recombinant galectin-1 on the growth and death of early hematopoietic cells. Stem Cells. 2005;23:279–287
  19. Albini A, Paglieri I, Orengo G, et al. The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma–derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS. 1997;11:713–721
  20. Raso E, Meszaros L, Albini A, Timar J. A WT1 expressing metastatic human Kaposi sarcoma xenograft model. Pathol Oncol Res. 2004;10:22–25
  21. Gauthier L, Rossi B, Roux F, Termine E, Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A. 2002;99:13014–13019
  22. Bradl H, Wittmann J, Milius D, Vettermann C, Jack HM. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell–associated heparan sulfate. J Immunol. 2003;171:2338–2348
  23. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood. 1990;76:2153–2158
  24. Neben S, Marcus K, Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood. 1993;81:1960–1967
  25. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973–981
  26. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood. 2004;103:1580–1585
  27. Pruijt JF, Verzaal P, van Os R, et al. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc Natl Acad Sci U S A. 2002;99:6228–6233
  28. Kollet O, Dar A, Shivtiel S, et al. Osteoclats degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12:657–664
  29. Wagers AJ, Allsopp RC, Weissman IL. Changes in integrin expression are associated with altered homing properties of Lin-/loThy1.1loSca-1+c-kit+ hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol. 2002;30:176–185
  30. Levesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol. 2002;30:440–449
  31. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111:187–196
  32. Wysoczynski M, Reca R, Ratajczak J, et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood. 2005;105:40–48
  33. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004;305:1000–1003
  34. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625–637
  35. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci U S A. 1997;94:1908–1913
  36. Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood. 2001;97:2278–2285
  37. He J, Baum LG. Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab Invest. 2006;86:578–590

PII: S0301-472X(06)00600-X

doi: 10.1016/j.exphem.2006.09.015

Experimental Hematology
Volume 35, Issue 2 , Pages 305-313 , February 2007

Article Tools

* Image Usage & Resolution